Top Medical Stocks To Buy Right Now

Fonar Co. (NASDAQ:FONR) Treasurer Raymond V. Damadian sold 900 shares of the stock in a transaction on Thursday, September 27th. The shares were sold at an average price of $24.68, for a total value of $22,212.00. Following the completion of the sale, the treasurer now directly owns 121,852 shares of the company’s stock, valued at $3,007,307.36. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

NASDAQ FONR opened at $24.90 on Friday. The firm has a market capitalization of $158.30 million, a P/E ratio of 7.81 and a beta of 2.17. Fonar Co. has a 12 month low of $21.10 and a 12 month high of $33.90.

Get Fonar alerts:

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FONR. Dimensional Fund Advisors LP raised its position in Fonar by 38.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 202,153 shares of the medical equipment provider’s stock valued at $6,024,000 after buying an additional 55,962 shares during the last quarter. JPMorgan Chase & Co. raised its position in Fonar by 3,420.9% in the 1st quarter. JPMorgan Chase & Co. now owns 46,934 shares of the medical equipment provider’s stock valued at $1,398,000 after buying an additional 45,601 shares during the last quarter. BlackRock Inc. raised its position in Fonar by 12.3% in the 2nd quarter. BlackRock Inc. now owns 348,576 shares of the medical equipment provider’s stock valued at $9,255,000 after buying an additional 38,123 shares during the last quarter. Polar Asset Management Partners Inc. raised its position in Fonar by 28.3% in the 1st quarter. Polar Asset Management Partners Inc. now owns 155,000 shares of the medical equipment provider’s stock valued at $4,619,000 after buying an additional 34,200 shares during the last quarter. Finally, Wells Fargo & Company MN raised its position in Fonar by 318.2% in the 1st quarter. Wells Fargo & Company MN now owns 35,498 shares of the medical equipment provider’s stock valued at $1,057,000 after buying an additional 27,009 shares during the last quarter. 52.67% of the stock is owned by institutional investors and hedge funds.

Top Medical Stocks To Buy Right Now: First Financial Bancorp.(FFBC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of First Financial Bancorp (NASDAQ:FFBC) from a hold rating to a buy rating in a research note released on Thursday morning.

  • [By Ethan Ryder]

    Press coverage about First Financial Bancorp (NASDAQ:FFBC) has been trending somewhat positive on Saturday, according to Accern. The research group scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. First Financial Bancorp earned a news impact score of 0.23 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 45.5407494849709 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Stephan Byrd]

    Shares of First Financial Bancorp (NASDAQ:FFBC) have received a consensus recommendation of “Hold” from the eleven research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $31.33.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on First Financial Bank (FFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    First Financial Bank (NASDAQ:FFBC) Chairman Claude E. Davis sold 19,379 shares of the stock in a transaction dated Thursday, May 10th. The shares were sold at an average price of $32.19, for a total transaction of $623,810.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Top Medical Stocks To Buy Right Now: Sundance Energy Australia Limited (SNDE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s analysis:

    Get SUNDANCE ENERGY/S alerts:

    SUNDANCE ENERGY/S (SNDE) Expected to Post Quarterly Sales of $31.40 Million (americanbankingnews.com) -$0.06 Earnings Per Share Expected for SUNDANCE ENERGY/S (SNDE) This Quarter (americanbankingnews.com) Sundance Energy Australia (NASDAQ: SNDE) – Day Three Breakout Notes (oilandgas360.com) Sundance Energy Australia (SNDE) Presents At EnerCom’s 23rd Annual Oil & Gas Conference – Slideshow (seekingalpha.com)

    SNDE has been the topic of a number of research analyst reports. Zacks Investment Research downgraded SUNDANCE ENERGY/S from a “hold” rating to a “sell” rating in a research report on Wednesday, June 27th. ValuEngine upgraded SUNDANCE ENERGY/S from a “sell” rating to a “hold” rating in a research report on Saturday, June 16th. Finally, Seaport Global Securities reiterated a “buy” rating on shares of SUNDANCE ENERGY/S in a research report on Monday, August 13th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $7.30.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on SUNDANCE ENERGY/S (SNDE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy Right Now: Transocean Inc.(RIG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market lost ground on Monday, although the declines in some major benchmarks were more extreme than others. A budding financial crisis in Turkey once again captured the attention of investors, as the threat of rising tariffs and escalating diplomatic tension could drive a wedge through the North Atlantic Treaty Organization at a critical time for the geopolitical environment in the region. The repercussions of recent events involving Turkey echoed around the world, and some companies felt the tremors more sharply than others. First Majestic Silver (NYSE:AG), Turkcell Iletisim Hizmetleri (NYSE:TKC), and Transocean (NYSE:RIG) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Ethan Ryder]

    Transocean LTD (NYSE:RIG) shares traded down 5.4% on Thursday . The stock traded as low as $8.03 and last traded at $8.35. 14,556,095 shares traded hands during mid-day trading, an increase of 5% from the average session volume of 13,824,703 shares. The stock had previously closed at $8.83.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Transocean (RIG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By John Bromels]

    Unless it’s not. Which it may not be. There’s a big cloud of uncertainty hanging over the company, in part thanks to its status as a very small fish in a very big deepwater ocean that’s full of huge, hungry competitors like Transocean (NYSE:RIG) and Ensco (NYSE:ESV). Questions also abound about its parent company, Seadrill (NYSE:SDRL).

  • [By Stephan Byrd]

    An issue of Transocean LTD (NYSE:RIG) debt rose 2.5% against its face value during trading on Wednesday. The high-yield debt issue has a 6.8% coupon and will mature on March 15, 2038. The bonds in the issue are now trading at $85.45. Price moves in a company’s debt in credit markets sometimes anticipate parallel moves in its share price.

  • [By Tyler Crowe]

    Three stocks on my watchlist that look incredibly cheap and will likely be high up on my next buy list are LGI Homes (NASDAQ:LGIH), U.S. Silica Holdings (NYSE:SLCA), and Transocean (NYSE:RIG). Here’s why they look compelling to me now and why Wall Street seems to be assigning them such modest valuations. 

Top Medical Stocks To Buy Right Now: ANSYS, Inc.(ANSS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    ANSYS, Inc. (NASDAQ:ANSS) hit a new 52-week high and low during mid-day trading on Wednesday . The company traded as low as $178.06 and last traded at $176.96, with a volume of 7894 shares changing hands. The stock had previously closed at $175.41.

  • [By Ethan Ryder]

    ANSYS (NASDAQ: ANSS) and Okta (NASDAQ:OKTA) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

  • [By Ethan Ryder]

    ANSYS (NASDAQ:ANSS) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a report released on Monday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ansys (ANSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy Right Now: Sina Corporation(SINA)

Advisors’ Opinion:

  • [By Steve Symington]

    You wouldn’t know it by the market’s knee-jerk reaction, but SINA Corp. (NASDAQ:SINA) just announced another stronger-than-expected quarter early Wednesday. Shares of the Chinese internet media company fell 10% when all was said and done today — though it’s not the first time we’ve seen the stock fall on positive news.

  • [By Garrett Baldwin]

    While that is happening in the Middle East, trouble is brewing in Washington. In addition to reports that a Russian Oligarch paid Trump’s lawyer $500,000, a U.S. telecom giant is now caught up with the same lawyer. AT&T Corporation (NYSE: T) confirmed Tuesday night that it paid Trump lawyer Michael Cohen for information on the administration. AT&T stock is up 0.6% in premarket hours.
    Four Stocks to Watch Today: TRIP, MTCH, FOXA, DIS
    Shares of TripAdvisor (Nasdaq: TRIP) popped nearly 20% after the company crushed earnings after the bell. In addition, the CFO Ernst Teunissen projected strong guidance for the rest of the year. The firm reported EPS of $0.30 on top of $378.0 million in revenue. Wall Street expected $0.16 per share on $360.84 million in revenue.
    Shares of Match Group (Nasdaq: MTCH) popped 3% after the company reported earnings after the bell. The dating site operator reported stronger than expected earnings and revenue figures on Tuesday. Overall, revenue jumped 36% compared to the same period in 2017. The firm also reported stronger than expected guidance. Of course, all anyone is talking about how Facebook Inc. (Nasdaq: FB) could impact the dating industry with its new plugin.
    Shares of 21st Century Fox (NYSE FOXA) are in focus as the firm prepares to report earnings before the bell. However, investors are more likely focused today on the expected bidding war between the Walt Disney Co. (NYSE: DIS) and Comcast Corporation (Nasdaq: CMCSA) to purchase key assets of the company. Fox is also tied up in a bidding war with Comcast to purchase British television provider Sky (OTC MKTS: SKYAY).
    Look for additional earnings reports from Booking Holdings (Nasdaq: BKNG), com International (Nasdaq: CTRP), Sina Corp. (Nasdaq: SINA), Albermarle Corp. (NYSE: ALB), Mylan Inc. (NYSE: MYL), SolarEdge Technologies (Nasdaq: SEDG), Wolverine World Wide (NYSE: WWW), IAC Interactive Corp. (NYSE: IAC), and Cavium Inc. (Nasdaq: CAVM).

    Eight Seconds

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on SINA (SINA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Leo Sun]

    Shares of SINA (NASDAQ:SINA) fell 7% on Aug. 8 after the Chinese internet company reported its second quarter earnings. Yet the decline, which brought SINA to a 52-week low, seemed unjustified, as the company easily beat analyst estimates.

  • [By Leo Sun]

    SINA (NASDAQ:SINA), one of China’s oldest internet companies, generates nearly 80% of its revenues from the social network Weibo (NASDAQ:WB). It spun off Weibo in 2014, but maintained a majority voting stake in the company. The rest of its revenue come from its network of portal sites and its fledgling fintech business.

  • [By Leo Sun]

    But as the U.S. market remains stuck in neutral, Chinese tech stocks have thrived, sparked by impressive growth figures and their detachment from U.S.-centered issues. Let’s examine three stocks in that industry which have already rallied more than 30% this month — Baozun (NASDAQ:BZUN), Weibo (NASDAQ:WB), and SINA (NASDAQ:SINA).

Top Medical Stocks To Buy Right Now: Bank Of Montreal(BMO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Bank of Montreal (BMO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Bank of Montreal (TSE:BMO) (NYSE:BMO) announced a quarterly dividend on Tuesday, August 28th, RTT News reports. Investors of record on Thursday, November 1st will be given a dividend of 0.96 per share by the bank on Tuesday, November 27th. This represents a $3.84 dividend on an annualized basis and a yield of 3.62%.

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:

    Get Bank of Montreal alerts:

    The Bank of Montreal (TSX:BMO) Data Breach: Is Now the Time to Load Up on Cybersecurity Stocks? (msn.com) Q3 2018 EPS Estimates for Bank of Montreal Decreased by Analyst (BMO) (americanbankingnews.com) Brokers Set Expectations for Bank of Montreal’s FY2018 Earnings (BMO) (americanbankingnews.com) Why Canada’s big banks aren’t too worried about household debt (business.financialpost.com) Former Lunenburg bank spared from becoming ‘another hipster café,’ says new owner (cbc.ca)

    Several equities analysts have issued reports on BMO shares. Zacks Investment Research upgraded shares of Bank of Montreal from a “sell” rating to a “buy” rating and set a $85.00 price objective for the company in a research note on Tuesday, May 1st. ValuEngine downgraded shares of Bank of Montreal from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. National Bank Financial upgraded shares of Bank of Montreal from a “sector perform” rating to an “outperform” rating in a research note on Thursday. Finally, Macquarie upgraded shares of Bank of Montreal from a “neutral” rating to an “outperform” rating in a research note on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $95.75.

Leave a Reply

Your email address will not be published. Required fields are marked *